Hydrocephalus Shunts Market Worth $360.01 Million, Globally, by 2028 at 3.4% CAGR - Exclusive Research Report by The Insight Partners

The Insight Partners
The Insight Partners

The hydrocephalus valves segment held the largest hydrocephalus shunts market share of 61.85% in 2021; The hospitals segment dominated the global market and held the largest market share of 54.99% in 2021; The ventriculo-peritoneal segment accounted for the largest market share of 44.44% in 2021.

New York, Sept. 22, 2022 (GLOBE NEWSWIRE) -- The Insight Partners published latest research study on “Hydrocephalus Shunts Market Size, Share, Revenue, Growth Strategy, Industry Trends and Forecast to 2028 - COVID-19 Impact and Global Analysis By Age Group, Type, Product, and End User”, the global hydrocephalus shunts market size is expected to grow from $286.19 million in 2021 to $360.01 million by 2028; it is estimated to grow at a CAGR of 3.4% from 2022 to 2028. The report highlights the key factors driving the market and prominent players with their developments. The growth of the hydrocephalus shunts market is primarily attributed to the increasing prevalence of hydrocephalus and advancements in hydrocephalus valves. However, the high cost of treatments involving shunts and the need for revision surgeries hamper the market growth.


Download Sample Brochure of Hydrocephalus Shunts Market Size - COVID-19 Impact and Global Analysis with Strategic Insights at: https://www.theinsightpartners.com/sample/TIPRE00028558/


Hydrocephalus Shunts Market Report Scope, Segmentations, Regional & Country Scope:

Report Coverage

Details

Market Size Value in

US$ 286.19 Million in 2021

Market Size Value by

US$ 360.01 million by 2028

Growth rate

CAGR of 3.4% from 2022 to 2028

Forecast Period

2022-2028

Base Year

2022

No. of Pages

205

No. of Tables

143

No. of Charts & Figures

79

Historical data available

Yes

Segments covered

Product, Type, Age Group, and End User

Regional scope

North America; Europe; Asia Pacific; Latin America; MEA

Country scope

US, UK, Canada, Germany, France, Italy, Australia, Russia, China, Japan, South Korea, Saudi Arabia, Brazil, Argentina

Report coverage

Revenue forecast, company ranking, competitive landscape, growth factors, and trends

Hydrocephalus Shunts Market Forecast to 2028 - Latest COVID-19 Analysis

https://www.theinsightpartners.com/covid-analysis-sample/TIPRE00028558/


Browse key market insights spread across 205 pages with 143 list of tables & 79 list of figures from the report, "Hydrocephalus Shunts Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Age Group (Pediatric and Adults), Type (Ventriculo-Peritoneal, Ventriculo-Atrial, Ventriculo-Pleural, and Lumbo-Peritoneal), Product (Hydrocephalus Valves, Hydrocephalus Catheters, Neuronavigation Systems, and Others), and End User (Hospitals, Ambulatory Surgical Centers, and Others)" in detail along with the table of contents: https://www.theinsightpartners.com/reports/hydrocephalus-shunts-market


Hydrocephalus Shunts Market: Competitive Landscape and Key Developments
B. Braun Melsungen AG (CHRISTOPH MIETHKE GMBH & CO. KG); Sophysa; HpBio Próteses, inc.; Integra LifeSciences Holdings Corporation; KANEKA MEDIX CORP.; Medtronic; Natus Medical Incorporated; Spiegelberg GmbH & Co. KG; and Desu Medical are among the key companies in the global hydrocephalus shunts market. These players are focusing on expanding, diversifying their market presence, and acquiring a novel customer base, thereby tapping prevailing business opportunities.

In May 2020, Aesculap, Inc. launched the M.blue valve in the US, in partnership with Christoph Miethke GmbH & Co. KG (MIETHKE). The M.blue valve features advanced gravitational technology, which is incorporated with a fixed differential pressure unit in one valve.


Inquiry Before Purchase: https://www.theinsightpartners.com/inquiry/TIPRE00028558/


In 2021, North America dominated the hydrocephalus shunts market. The US is a major contributor to the market in this region mainly due to better healthcare infrastructure supporting the adoption of technologically advanced shunts, and growing awareness about hydrocephalus in the country. According to the National Institute of Neurological Disorders and Stroke (NINDS), hydrocephalus is projected to affect ~1–2 in every 1,000 children born in the US. Per the Los Angeles Health Organization, the University of California, ~125,000 people in the US are currently living with cerebrospinal fluid shunts. Companies in the hydrocephalus shunts market in this country are adopting organic and inorganic strategies such as acquisitions. For instance, in June 2020, Rhaeos, Inc. received FDA Breakthrough Device Designation for its “FlowSense” noninvasive thermal sensor. The sensor detects CSF flow in hydrocephalic patients. Such product launches and developments are expected to boost the growth of the hydrocephalus shunts market in the US.

Increasing Prevalence of Hydrocephalus Boosts Hydrocephalus Shunts Market Growth:
Cerebrospinal fluid (CSF) in the brain and spinal cord protects the central nervous system from injuries and infections. The accumulation of excess CSF in brain cavities adds to intracranial pressure, thereby leading to hydrocephalus. The condition may further lead to macrocephaly and cognitive dysfunctions. Hydrocephalus is more prevalent in children and infants than in adults. Additionally, the disease is also prevalent in people aged 60 and above.


Speak to Research Expert: https://www.theinsightpartners.com/speak-to-analyst/TIPRE00028558


According to the Hydrocephalus Association, the disease affects over 1 million Americans. Additionally, the incidence rate of hydrocephalus in the US is 1 in every 770 babies. According to the article "Global hydrocephalus epidemiology and incidence: systematic review and meta-analysis," published in the Journal of Neurosurgery (JNS) in 2019, low-income and middle-income countries, particularly those in Africa and Latin America, incur the most significant burden of hydrocephalus. The article also states that Sub-Saharan Africa witnessed an annual incidence of more than 225,000 new cases of infant hydrocephalus, i.e., 750 new cases per 100,000 live births. Moreover, in a European cohort, the incidence rate was estimated at 110 cases of infantile hydrocephalus per 100,000 live births.

The treatment approach of hydrocephalus highly focuses on managing CSF through medical devices named shunts. The shunt systems remove excess cerebrospinal fluid from the brain and divert it to other body parts, wherein it is absorbed as a part of the circulatory process. Thus, the high incidence of hydrocephalus leads drives the demand for hydrocephalus shunts, thereby boosting the hydrocephalus market growth.

Hydrocephalus Shunts Market: Segmental Overview
Based on product, the hydrocephalus shunts market is segmented into hydrocephalus valves, hydrocephalus catheters, neuronavigation systems, and others. In 2021, the hydrocephalus valve segment accounted for the largest market share, and the same segment is anticipated to register the highest CAGR from 2022 to 2028.


Get Discount on “Hydrocephalus Shunts Market” Research Study: https://www.theinsightpartners.com/discount/TIPRE00028558/


Based on type, the hydrocephalus shunts market is segmented into ventriculo-peritoneal, ventriculo-atrial, ventriculo-pleural, and lumbo-peritonea. The ventriculo-peritoneal segment held the largest market share in 2021, and it is expected to register the highest CAGR during the forecast period.

Based on age group, the hydrocephalus shunts market is bifurcated into pediatric and adults. The pediatric segment held a larger market share in 2021, and it is expected to register a higher CAGR during the forecast period.

Based on end user, the hydrocephalus shunts market is segmented into hospitals, ambulatory surgical centers, and others. The hospital segment held the largest market share in 2021, and it is expected to register the highest CAGR during the forecast period.


Buy Premium Copy of Hydrocephalus Shunts Market Growth Report (2022-2028) at: https://www.theinsightpartners.com/buy/TIPRE00028558/




Browse Similar Market Research Studies:
Neuronavigation Systems Market Forecast to 2028 - Covid-19 Impact and Global Analysis - By Type (Electromagnetic System and Optical System); Application (Neurosurgery, ENT Surgery, Spinal Surgery, and Maxillofacial Surgery) and Geography

Neurosurgical Products Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Shunts, Neurosurgical endoscopes, Stereo tactic radiosurgery systems, Embolization products, Aneurysm and AVM clips, Others); Condition (Aneurysms, Pituitary and Intracranial tumors, Arteriovenous malformations, Hydrocephalus, Others); Surgery (Minimally Invasive Surgery, Open Surgery) and Geography

Ventricular Drainage Sets Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Ventricular Drainage Set, and Accessories); Application (Intraventricular Hemorrhage, Intracranial Hypertension, Hydrocephalus, CSF Infection, and Others); End Use (Hospitals, Ambulatory Surgical Centers, and Others), and Geography

Left Ventricular Assist Device Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type of flow (Pulsatile Flow, Non-pulsatile); Design (Implantable ventricular assist devices, Transcutaneous ventricular assist devices); Application (Bridge to transplantation, Destination therapy, Bridge to recovery and Bridge to candidacy)

Implantable Ventricular Assist Devices Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Left Ventricular Assist Device (LVAD), Right Ventricular Assist Device (RVAD), Biventricular Assist Device (BiVAD), Total Artificial Heart (TAH)); Application (Bridge-To-Transplant (BTT) Therapy, Destination Therapy, Other Therapies)

Ventricular Assist Device Market Forecast to 2028 - Covid-19 Impact and Global Analysis - By By Product (Biventricular assist devices, Left ventricular assist devices, Right ventricular assist devices), By Type (Implantable ventricular assist devices, Transcutaneous ventricular assist devices), By Application (Destination therapy, Bridge-to-recovery therapy, Bridge-to-transplant therapy, Bridge-to-candidacy therapy), and Geography

Neurosurgical Robotics Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Component [Equipment/System (Robot Machines, Navigation System, Planner & Simulators, and Others), Accessories, and Services], Application [Spinal (Laminectomy, Discectomy, Spinal Fusion, Disc Replacement, Foraminotomy, and Others) and Cranial (Craniotomy, Brain Biopsy, Thermal ablation of Seizure and Others)], Surgery Type (Minimally Invasive and Open Surgery), and End Users (Hospitals, Specialty Clinics, and Others)

Neurological Biomarker Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Product (Proteomics Biomarker, Genomics Biomarker, Metabolomics Biomarker, Imaging Biomarker, Others); Application (Alzheimer's Disease, Parkinson's Disease, Schizophrenia, Huntington's Disease, Spinal Muscular Atrophy, Others); End User (Pharmaceutical and Biotechnology Companies, Clinical Diagnostics, Research Organizations); and Geography

Intraoperative Neuromonitoring Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Product (into Systems, Accessories, Services); Source (Insourced Monitoring, Outsourced Monitoring); Application (Spinal Surgery, Neurosurgery, Vascular Surgery, ENT Surgery, Orthopedic Surgery, Other Surgeries); Modality (Motor Evoked Potentials, Somatosensory Evoked Potentials, Electroencephalography, Electromyography, Brainstem Auditory Evoked Potentials, Visual Evoked Potentials); End User (Hospitals, Ambulatory Surgical Centers); and Geography

Neurointerventional Devices Market to 2027 - Global Analysis and Forecasts By Type Type (Neurovascular Thrombectomy Devices, Neurovascular Stents, Embolic Protection Devices, Intrasaccular Devices, Embolic Coils, Flow Diverters, Liquid Embolics, Balloons, and Stent Retrievers); Technique (Neurothrombectomy, Stenting, Coiling Procedure, Cerebral Angiography, Flow Disruption); End User (Hospitals, Ambulatory Surgical Centers) and Geography

Interventional Neuroradiology Market to 2027- Global Analysis and Forecasts by Product (Neurovascular Embolization & Coiling Assist Devices, Accessories); Disease (Cerebral Aneurysms, Intra-Cranial Tumors, Acute Strokes, Intra-Cranial Tumors, Others); End User (Hospitals, Ambulatory Surgical Centers, Other End Users) and Geography




About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.

Contact Us:
If you have any queries about this report or if you would like further information, please contact us:

Contact Person: Sameer Joshi
E-mail: sales@theinsightpartners.com
Phone: +1-646-491-9876
Press Release: https://www.theinsightpartners.com/pr/hydrocephalus-shunts-market
Industry Research: https://www.biospace.com/employer/2309254/tip-knowledge-services-pvt-ltd-/